Sean Nolan, Taysha Gene Therapies CEO
Taysha raises $150M PIPE, shares single patient data on Rett syndrome gene therapy
Taysha Gene Therapies announced it raised $150 million from a stock sale to investors as it unveiled data from a single …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
